Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 0.42 |
| ▸ | MAOA | P21397 | 10/20 | 0.42 |
| ▸ | USP8 | P40818 | 1/20 | 0.39 |
| ▸ | USP7 | Q93009 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | UPP1 | Q16831 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3027435 | 0.83 | ALDH1A1 (0.61) | MAOBMAOAALDH1A1KDM4EUSP2 | |
| SCHEMBL4486770 | 0.78 | TRPV4 (0.57) | TRPV4 | |
| SCHEMBL17796258 | 0.78 | TSHR (0.48) | USP8USP7ALDH1A1KDM4EUSP2 | |
| SCHEMBL518867 | 0.78 | TRPV4 (0.57) | TRPV4 | |
| SCHEMBL17796254 | 0.78 | TSHR (0.48) | ALDH1A1KDM4EUSP2TRPV4 | |
| SCHEMBL4466578 | 0.78 | TRPV4 (0.43) | TRPV4 | |
| SCHEMBL8516131 | 0.78 | XDH (0.46) | ALDH1A1KDM4EUSP2TRPV4LMNA | |
| SCHEMBL11837307 | 0.73 | AR (0.53) | ALDH1A1KDM4EUSP2 | |
| SCHEMBL16277098 | 0.72 | ALDH1A1 (0.52) | MAOBMAOAALDH1A1KDM4EHTT | |
| SCHEMBL3022943 | 0.70 | TRPV4 (0.32) | USP8USP7TRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113631661-B | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2023-11-07 | — | — | CN | disclosed |
| CN-113454167-B | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2023-08-15 | — | — | CN | disclosed |
| CN-114575144-A | Corrosion-resistant degradable antibacterial hemp fiber fishing net and preparation method thereof | 东嘉麻棉(常州)有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-107024834-B | Compound and coloring composition | 住友化学株式会社 | 2021-11-23 | — | — | CN | disclosed |
| CN-113631661-A | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2021-11-09 | — | — | CN | disclosed |
| CN-113454167-A | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2021-09-28 | — | — | CN | disclosed |
| CN-113264918-A | Coloring composition, compound, color filter and display device | 住友化学株式会社 | 2021-08-17 | — | — | CN | disclosed |
| EP-3385251-B1 | PHTHALONITRILE COMPOUND | LG CHEMICAL LTD (KR) | 2019-10-09 | — | — | EP | disclosed |
| EP-1957073-B1 | MEDICINAL DRUG | OTSUKA PHARMA CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| EP-2612858-A1 | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-20070270422-A1 | Aromatic Compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| WO-2007066784-A2 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | WO | disclosed |
| EP-1773797-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014012-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |
| US-6867200-B1 | (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-15 | — | — | US | disclosed |
| US-20030232789-A1 | Salicylamides as serine protease and factor xa inhibitors | ALLEN DARIN ARTHUR (US) | 2003-12-18 | — | — | US | disclosed |
| US-20030225036-A1 | Non-amidine containing protease inhibitors | AXYS PHARMACEUTICALS, INC. | 2003-12-04 | — | — | US | disclosed |
| EP-1242366-A1 | SALICYLAMIDES AS SERINE PROTEASE AND FACTOR XA INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-09-25 | — | — | EP | disclosed |
| US-20020052343-A1 | Salicylamides as serine protease inhibitors | AXYS PHARMACEUTICALS, INC. | 2002-05-02 | — | — | US | disclosed |
| WO-2001044172-A1 | SALICYLAMIDES AS SERINE PROTEASE AND FACTOR XA INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232789-A1 | Salicylamides as serine protease and factor xa inhibitors | TFPI, HABP2, PLAT | MAOB 269/4885MAOA 143/4885USP8 530/4885 |
| US-20030225036-A1 | Non-amidine containing protease inhibitors | TFPI, SERPINE1, HABP2 | MAOB 293/4885MAOA 210/4885USP8 1992/4885 |
| US-20020052343-A1 | Salicylamides as serine protease inhibitors | TFPI, SERPINE1, HABP2 | MAOB 409/4885MAOA 190/4885USP8 419/4885 |
| US-20070270422-A1 | Aromatic Compounds | COL1A1, COL2A1, COL14A1 | MAOB 402/4885MAOA 317/4885USP8 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.